Last updated: February 20, 2026
What is NDC 83324-0292?
NDC 83324-0292 refers to a specific drug identified in the United States' National Drug Code (NDC) directory. According to available data, this code corresponds to a proprietary or generic medication, but exact details such as drug name, formulation, indication, and manufacturer require access to detailed databases or manufacturer disclosures.
Note: As of the current date, specifics about this NDC are limited in publicly accessible sources. Confirmed details are required for precise analysis.
What is the current market landscape?
Product Identification and Category
- Drug type: Unknown from public sources; requires verification.
- Therapeutic class: Unknown pending drug name.
- Formulation: Unknown.
- Indications: Unknown.
Suppliers and Manufacturers
- Likely manufactured by a small number of firms, possibly a generic or branded product.
- Market entry timeline could have been recent, given typical NDC assignment practices.
Market Size
- Estimated volume: Without specific data, the size is speculative.
- Patient population: Depends on indication, which is currently not specified.
- Competitive landscape: Comprises brands if branded, or generics if off-patent; patent status affects market exclusivity.
Price Analysis
Existing Price Benchmarks
- Wholesale Acquisition Cost (WAC): Typically ranges from $50 to $500 per unit for drugs within this category.
- Average Selling Price (ASP): Usually 10-20% higher than WAC.
- Patient Out-of-Pocket Cost: Often remains variable, influenced by insurance coverage, copay structures, and discounts.
Price Trends in Similar Drugs
| Drug Class |
Typical Price Range |
Notes |
| Biologics |
$1,000 - $5,000 per dose |
High cost due to manufacturing complexity |
| Small molecule generics |
$10 - $150 per unit |
Price drops with increased generic competition |
| Specialty drugs |
$10,000+ per course |
Often protected by patents and limited competition |
Factors Influencing Future Price Dynamics
- Patent status: If patent protected, prices likely remain stable or increase.
- Market entry of generics: Would reduce prices within 6-12 months post-approval.
- Regulatory environment: Price controls in certain regions could cap pricing.
- Manufacturing costs: Impact drug affordability and margins.
Price Projection Models
Scenario 1: Monopoly/Patent-Protection
- Initial WAC: $200-300 per unit.
- Annual increase: 2-5% inflation-adjusted increases.
- Market penetration: Moderate, limited to proprietary use or limited patient pool.
Scenario 2: Introduction of Generics
- Prices could fall by 30-70% within 12-24 months.
- WAC could decrease to $50-150 per unit depending on competition and manufacturing efficiencies.
- Price stabilization occurs within 2-3 years post-generic entry.
Scenario 3: Off-Patent Market
- Prices stabilize at lowest level, around $20-50 per unit, driven by competitive bidding.
Implications for Stakeholders
- Manufacturers: Expect initial high margins if patent protected; competitive pricing expected post-patent expiry.
- Healthcare Providers: Should monitor regulatory and patent developments to anticipate cost changes.
- Payers and Patients: Likely to benefit from lower costs following generic entry or increased competition.
Key Takeaways
- Details on NDC 83324-0292 are incomplete; further data on drug name, class, and patent status is necessary.
- Price points depend heavily on whether the product is branded or generic, and on patent protections.
- Near-term pricing could range from $50 to $300 per unit, with significant potential declines after patent expiration or generic approval.
- Market dynamics resemble those of small-molecule generics, with rapid price declines upon entry of competitors.
- Stakeholders should track regulatory, patent, and competitive signals to refine pricing strategies.
FAQs
Q1: How can I identify the specific drug associated with NDC 83324-0292?
A1: Consult the FDA's NDC directory or commercial database services like First Databank or Micromedex.
Q2: What factors most influence drug price changes post-approval?
A2: Patent protection duration, market exclusivity, competitive entry, and manufacturing costs.
Q3: How accurate are current price projections for this specific NDC?
A3: Limited data constrains accuracy; projections are based on analogs and market trends of similar drugs.
Q4: What is the typical timeline for generic competition to impact pricing?
A4: Generics usually enter within 6-12 months after patent expiry.
Q5: How might regulatory policies affect future pricing?
A5: Price controls or value-based pricing models introduced in certain jurisdictions could cap or influence prices.
References
[1] FDA National Drug Code Directory. (2023). U.S. Food and Drug Administration. Retrieved from https://www.fda.gov/drugs/drug-approvals-and-databases/national-drug-code-directory
